A novel behavioral three-way decision model with application to the treatment of mild symptoms of COVID-19

The Coronavirus Disease 2019 (COVID-19) has popularized since late December 2019. In present, it is still highly transmissible and has severe impact on the public health and global economy. Due to the lack of specific drug and the appearance of different variants, the selection of the antiviral ther...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shi-Fan, Wang, Ying-Ming, Pan, Xiaohong, Chin, Kwai-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132434/
https://www.ncbi.nlm.nih.gov/pubmed/35637858
http://dx.doi.org/10.1016/j.asoc.2022.109055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132434/
https://www.ncbi.nlm.nih.gov/pubmed/35637858
http://dx.doi.org/10.1016/j.asoc.2022.109055

Ejemplares similares